Armstrong Advisory Group’s Microchip Technology MCHP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.59K Sell
59
-76
-56% -$5.92K ﹤0.01% 808
2026
Q2
$12.3K Hold
135
– – ﹤0.01% 680
2026
Q1
$8.72K Hold
135
– – ﹤0.01% 715
2025
Q4
$8.6K Hold
135
– – ﹤0.01% 696
2025
Q3
$8.67K Hold
135
– – ﹤0.01% 707
2025
Q2
$9.5K Sell
135
-184
-58% -$10.1K ﹤0.01% 678
2025
Q1
$18.3K Hold
319
– – ﹤0.01% 534
2024
Q4
$18.3K Hold
319
– – ﹤0.01% 534
2024
Q3
$25.6K Buy
319
+41
+15% +$3.38K ﹤0.01% 463
2024
Q2
$25.4K Sell
278
-778
-74% -$71.2K ﹤0.01% 455
2024
Q1
$95.2K Hold
1,056
– – 0.01% 260
2023
Q4
$95.2K Buy
1,056
+921
+682% +$75K 0.01% 260
2023
Q3
$10.5K Hold
135
– – ﹤0.01% 592
2023
Q2
$12.1K Hold
135
– – ﹤0.01% 552
2023
Q1
$11.3K Hold
135
– – ﹤0.01% 547
2022
Q4
$9.48K Buy
+135
New +$9.3K ﹤0.01% 595

Other funds holding MCHP

Armstrong Advisory Group's MCHP Position: Q3 2026 in Review

Armstrong Advisory Group reduced its Microchip Technology (MCHP) stake by 56% in Q3 2026, selling an estimated $5.92K and leaving 59 shares worth $4.59K. The position accounts for ﹤0.01% of the portfolio, ranked #808.

Armstrong Advisory Group first reported a position in MCHP in Q4 2022 and has held it in 16 quarters since. The position peaked at $95.2K in Q1 2024. 314 funds tracked by Wall St. Rank hold MCHP as of Q3 2026.

  • Armstrong Advisory Group held 59 shares of Microchip Technology worth $4.59K as of Q3 2026.
  • Armstrong Advisory Group sold 76 Microchip Technology shares in Q3 2026, an estimated $5.92K.
  • Microchip Technology made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #808 holding.
  • Armstrong Advisory Group first reported a position in Microchip Technology in Q4 2022 and has held it in 16 quarters since.
  • Armstrong Advisory Group's Microchip Technology position peaked at $95.2K in Q1 2024.
  • 314 funds tracked by Wall St. Rank held Microchip Technology as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.